Markets & Finance

Jefferies Upgrades Varian Medical

Jefferies & Co. upgraded its recommendation on Varian Medical Systems (VAR) to buy from hold.

Analyst Ryan Rauch tells Standard & Poor's MarketScope he believes the Image-Guided Radiotherapy Technology (IGRT) cycle is real. He says the company recently said it expects to report 19% worldwide oncology growth, vs. his ll% estimate. Rauch notes 61% of respondents from a survey indicated they plan to buy IGRT upgrades or IGRT-ready machines within the next 12 months. The analyst notes the majority of those that plan to buy IGRT upgrades indicated the supplier would be Varian.

Toyota's Hydrogen Man
blog comments powered by Disqus